Compounds > 1,4-bis(2-(3,5-dichloropyridyloxy))benzene
Page last updated: 2024-11-04

1,4-bis(2-(3,5-dichloropyridyloxy))benzene and Atherosclerosis

1,4-bis(2-(3,5-dichloropyridyloxy))benzene has been researched along with Atherosclerosis in 2 studies

1,4-bis(2-(3,5-dichloropyridyloxy))benzene: potent phenobarbital-like inducer of microsomal monooxygenase activity; structure given in first source

Atherosclerosis: A thickening and loss of elasticity of the walls of ARTERIES that occurs with formation of ATHEROSCLEROTIC PLAQUES within the ARTERIAL INTIMA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sberna, AL2
Assem, M2
Gautier, T2
Grober, J2
Guiu, B2
Jeannin, A1
Pais de Barros, JP2
Athias, A1
Lagrost, L2
Masson, D2
Xiao, R1
Ayers, S1
Deckert, V1
Chevriaux, A1
Le Guern, N1
Moore, DD1

Other Studies

2 other studies available for 1,4-bis(2-(3,5-dichloropyridyloxy))benzene and Atherosclerosis

ArticleYear
Constitutive androstane receptor activation stimulates faecal bile acid excretion and reverse cholesterol transport in mice.
    Journal of hepatology, 2011, Volume: 55, Issue:1

    Topics: Animals; Apolipoproteins E; Atherosclerosis; ATP Binding Cassette Transporter, Subfamily G, Member 5

2011
Constitutive androstane receptor activation decreases plasma apolipoprotein B-containing lipoproteins and atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Arteriosclerosis, thrombosis, and vascular biology, 2011, Volume: 31, Issue:10

    Topics: Amino Acid Sequence; Animals; Apolipoprotein B-100; Apolipoproteins B; Apolipoproteins E; Atheroscle

2011